14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today RDHL ranks #13599 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Redhill Biopharma Ltd. Stock Forecast NASDAQ:RDHL

$3.19 (7.77%)

Volume: 1M

Closed: Dec 08, 2021

Hollow Logo Score: -1.471

Redhill Biopharma Ltd. Stock Forecast

$3.19 (7.77%)

Volume: 1M

Closed: Dec 08, 2021

Score Hollow Logo -1.471
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 35 and the stock is currently not being overbought or oversold

Volatile ride for Redhill Biopharma Ltd. stock price on Wednesday moving between $2.88 and $3.37
(Updated on Dec 08, 2021)


Sell candidate since 2021-11-11 Loss -35.29%

The Redhill Biopharma Ltd. stock price gained 7.77% on the last trading day (Wednesday, 8th Dec 2021), rising from $2.96 to $3.19. , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 17.01% from a day low at $2.88 to a day high of $3.37. The price has risen in 7 of the last 10 days and is up by 17.28% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 284 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $3.68 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -31.52% during the next 3 months and, with a 90% probability hold a price between $1.66 and $4.15 at the end of this 3-month period.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, December 03, 2021, and so far it has risen 25.10%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Redhill Biopharma Ltd. stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $4.30. On a fall, the stock will find some support from the short-term average at $2.82. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss

On the downside, the stock finds support just below today's level from accumulated volume at $2.83 and $2.73. There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Redhill Biopharma Ltd. finds support just below today's level at $2.83. If this is broken, then the next support from accumulated volume will be at $2.73 and $2.72.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.49 between high and low, or 17.01%. For the last week, the stock has had a daily average volatility of 12.18%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Redhill Biopharma Ltd. stock A Buy?

Redhill Biopharma Ltd. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.471

Predicted Opening Price for Redhill Biopharma Ltd. of Thursday, December 9, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 9, 2021 Current price
$3.15 $3.19 (Overvalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Dec 01, 2021 "BTIG Research" gave "$16.00 - $10.00" rating for RDHL. The price target was changed from $2.73 to 6.5%.

Volatility and Risk
Daily Average Volatility: 12.18 %
Overall Risk: Very High High Medium Low Very Low
Volatility
12.18 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $3.88
Price: $3.19
Support: $2.83

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 3.64 14.00 %
3.45 8.13 %
3.33 4.51 %
Current price: 3.19
Support 2.96 -7.23 %
2.84 -10.85 %
2.66 -16.72 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 0 .
0 .
3.88 21.63 %
Current price 3.19
Support 2.83 -11.29%
2.73 -14.42%
2.72 -14.73%

Click to get the best stock tips daily for free!

About Redhill Biopharma Ltd.

Redhill Biopharma Ltd RedHill Biopharma Ltd., a biopharmaceutical company, primarily focuses on the development and commercialization of late clinical-stage, proprietary, and orally-administered small molecule drugs for the treatment of inflammatory and gastrointestinal diseases, and cancer. Its pipeline of proprietary products include RHB-105, an oral combination therapy for the treatment of helicobacter pylori infection, which has completed Phase III study; RHB-104,... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT